Selective Inhibition of ADAM28 Suppresses Lung Carcinoma Cell Growth and Metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selective Inhibition of ADAM28 Suppresses Lung Carcinoma Cell Growth and Metastasis

Published:2018-09-06 Issue:11 Volume:17 Page:2427-2438
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Mochizuki Satsuki,Shimoda Masayuki,Abe Hitoshi,Miyamae Yuka,Kuramoto Junko,Aramaki-Hattori Noriko,Ishii Ken,Ueno Hideki,Miyakoshi Akira,Kojoh Kanehisa,Okada Yasunori

Funder

JSPS KAKENHI Grant

Adaptable & Seamless Technology Transfer Program through target-driven R&D of JST (A-STEP)

Adaptable & Seamless Technology Transfer Program through Target-driven R&D of JST (A-STEP)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ADAM12 as a Clinical Prognostic Indicator Associated with Tumor Immune Infiltration in Lung Adenocarcinoma;DNA and Cell Biology;2022-04-01

2. Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options;Cells;2021-08-13

3. The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer;Frontiers in Oncology;2021-05-11

4. ADAM28 from both endothelium and gastric cancer cleaves von Willebrand Factor to eliminate von Willebrand Factor-induced apoptosis of gastric cancer cells;European Journal of Pharmacology;2021-05

5. Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics;Cellular Oncology;2021-04-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP